ϳԹ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • ϳԹ News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Oct 13 2022

Full Issue

Repurposed Diabetes Drugs In High Demand For Weight Loss

But questions linger about whether the cost is worth it for drugs such as Wegovy and its cousin Ozempic, which has been called a "Hollywood drug.” Plus, other updates on physical fitness, stress eating, and Noom.

At least once a day, Nancy Rahnama’s clinical nutrition practice in Beverly Hills, Calif., gets a call from a patient looking for a diabetes drug that they’ve heard can help them lose weight fast. “They specifically say, ‘How much is it to get Ozempic?’” Dr. Rahnama said. Ozempic, which is taken by injection in the thigh, stomach or arm, was approved by the Food and Drug Administration in 2017 to help lower blood sugar in people with Type 2 diabetes. One Ozempic injection pen typically lasts about a month and costs about $900 before insurance, though coverage can be hard to come by. (O'Brien, 10/12)

KHN: New Generation Of Weight Loss Medications Offer Promise — But At A Price 

Excitement is building about a new generation of drugs that tout the ability to help adults with excess weight shed more pounds than older drugs on the market. Some patients, obesity medicine specialists say, are experiencing decreases in blood pressure, better-managed diabetes, less joint pain, and better sleep from these newfound treatments. (Appleby, 10/13)

Is your body fat fit? It could be, if you start or continue exercising, according to rousing new science, which shows that being physically active alters fat at a molecular level in ways that improve the fat’s health. The findings have broad implications for the state of our metabolisms, muscles and even how well our bodies deal with the approaching holiday season of cheery gluttony. Many of us may not realize that body fat can be metabolically healthy — or the reverse — no matter what someone’s weight or shape. (Reynolds, 10/12)

Concerns about inflation, the economy, the lingering effects of the pandemic and other global crises have caused stress levels in the United States to surge to new highs. For some people, that stress is showing up on the scale. There are many biological mechanisms that explain why stress and anxiety can cause people to pack on unwanted pounds. In some cases, gaining weight can itself become a source of stress and stigma that fuels further weight gain. (O'Connor, 10/11)

The layoffs come as the company is attempting to shift toward a more enterprise-focused offering rather than reliance on direct-to-consumer offerings. Last Thursday, the company rolled out an offering called Noom for Work. (Turner, 10/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • ϳԹ
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF